Conduct HIT-to-lead progression studies on intervention agents: VIF/apobec inhibitors

Ended Awarded Last action

Contract number
HHSN27200008
Awardee
Awarding agency
Obligated
$350,539

Award facts

Contract value 100% obligated
$350,539.12 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN81 R&D- Medical: Aids Research (Basic Research)
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Birmingham, AL 35205, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 · The contractor shall conduct HIT-to-lead progression studies on two leads that are known to inhibit the interaction of VIF and APOBEC3G. -$1,119
Other Administrative Action 1 $0
Original award $351,658

Quick answers

Who was awarded contract HHSN27200008?

HHSN27200008 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 16, 2014.

How much is contract HHSN27200008 worth?

The government has obligated $350,539 on HHSN27200008.

Is contract HHSN27200008 an order under another contract?

Yes. HHSN27200008 is a delivery order under HHSN272201400010I, an indefinite delivery contract.

Was contract HHSN27200008 competed?

The extent of competition for HHSN27200008 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award